Spyglass Pharma Inc
Officers & Directors
Patrick Mooney, age 52, has served as Chief Executive Officer and Director since July 2021. He previously held leadership positions at Novartis and Alcon and earned a B.B.A. in marketing from the University of Wisconsin-Whitewater. Malik Y. Kahook, M.D., age 51, is Co-founder, President, and Chief Medical Officer since August 2024, Executive Chair of the Board since January 2021, and a Director. He is a professor and The Slater Family Endowed Chair in Ophthalmology at the University of Colorado Health. Dr. Kahook holds a B.S.N. from The University of Akron and an M.D. from Northeast Ohio Medical University. James Dennewill, age 45, has been Chief Operating Officer since October 2021. He previously held leadership roles at Cianna Medical and holds a B.S. in finance and operations from California State University, Long Beach, as well as an M.B.A. from Yale School of Management. Chetan Pujara, Ph.D., age 56, has served as Chief Research and Development Officer since February 2025. He previously worked at Osanni Bio, AbbVie, Allergan, and Abbott. Dr. Pujara holds a B.Pharm from Birla Institute of Technology and Science, Pilani, and a Ph.D. in pharmaceutical sciences from Purdue University. Jean-Frédéric Viret, Ph.D., age 60, has been Chief Financial Officer since January 2026. He previously served as CFO at NGM Biopharmaceuticals, Inc., Shasqi, Inc., and Blade Therapeutics, Inc.
|
